Mochida Pharmaceutical Co.,Ltd. Logo

Mochida Pharmaceutical Co.,Ltd.

An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.

4534 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区四谷一丁目7番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mochida Pharmaceutical Co., Ltd. is a research and development-driven company engaged in the manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. The company's core pharmaceutical business focuses on developing innovative drugs in targeted therapeutic areas, including cardiovascular medicine, obstetrics and gynecology, psychiatry, and gastroenterology. Its operations span from R&D and manufacturing of various formulations, such as injectables and oral solids, to marketing and sales. In addition to its prescription drug portfolio, Mochida also develops and provides skincare and other healthcare-related products.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Mochida Pharmaceutical Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-01 03:25
Regulatory News Service
臨時報告書
Japanese 28.8 KB
2025-06-27 06:50
Regulatory News Service
確認書
Japanese 8.7 KB
2025-06-27 06:49
Regulatory News Service
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 24.7 KB
2025-06-27 06:43
Annual Report
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2024-11-11 01:36
Regulatory News Service
確認書
Japanese 8.7 KB
2024-11-11 01:35
Interim Report
半期報告書-第87期(2024/04/01-2025/03/31)
Japanese 192.6 KB
2024-06-28 06:36
Regulatory News Service
臨時報告書
Japanese 28.0 KB
2024-06-27 07:03
Regulatory News Service
確認書
Japanese 8.7 KB
2024-06-27 07:02
Regulatory News Service
内部統制報告書-第86期(2023/04/01-2024/03/31)
Japanese 23.5 KB
2024-06-27 07:01
Annual Report
有価証券報告書-第86期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-02-13 02:30
Regulatory News Service
確認書
Japanese 8.7 KB
2024-02-13 02:29
Quarterly Report
四半期報告書-第86期第3四半期(2023/10/01-2023/12/31)
Japanese 161.3 KB
2023-11-13 01:38
Regulatory News Service
確認書
Japanese 8.7 KB
2023-11-13 01:34
Quarterly Report
四半期報告書-第86期第2四半期(2023/07/01-2023/09/30)
Japanese 197.9 KB
2023-08-09 02:20
Regulatory News Service
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Mochida Pharmaceutical Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mochida Pharmaceutical Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.